Background/Purpose Antiplatelet therapy is the cornerstone for acute ischemic stroke or
transient ischemic attack (TIA). The purpose of this study was to conduct a meta-analysis to …

Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …

Rationale The risk of recurrent ischemia is high in the acute period after ischemic stroke and
transient ischemic attack. Aspirin is recommended by guidelines for this indication, but more …

Background Aspirin is a cornerstone of preventive treatment for stroke recurrence, but during
the last few years the role of dual antiplatelet therapy (DAPT) is much more emerging …

Introduction: Ischemic stroke (IS) is a major cause of death and disability worldwide. The
P2Y12 receptor plays a critical role in the formation of a stable thrombus leading to ischemic …

Background: P2Y12 inhibitors have been widely used as an alternative to aspirin in clinical
practice for secondary stroke prevention. We aimed to compare the efficiency and safety of …

Introduction: While various antiplatelet regimens are currently available for secondary
prevention after ischemic stroke, data comparing their efficacy and safety are scarce. We …

Background: Dual antiplatelet therapy (DAPT) is recommended after minor ischemic
stroke/transient ischemic attack (TIA), but Clopidogrel/Aspirin has never been compared …

Background and Purpose—The role of aspirin plus clopidogrel (A+ C) therapy compared
with aspirin monotherapy in patients presenting with acute ischemic stroke (IS) or transient …

BACKGROUND: The atherosclerotic sources of embolism are a significant contributor to
embolic stroke of undetermined source (ESUS). However, there is limited evidence for the …